Welcome to the UPF Digital Repository

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)



Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)

Thumbnail
Document Type: Article
Version: Published version
Date: 2017
This document is associated with a Creative Common license © Adela Martínez-Martí et al 2017. Published by Oxford University Press. This is an Open Access article distributed under the terms of a Creative Commons Attribution License
Thumbnail

This item appears in the following Collection(s)

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking